ARTICLE | Product Development
ASGCT presentations showcase cancers, infectious diseases and chronic inflammatory conditions as potential applications of vectorized antibodies
By Lauren Martz, Executive Director, Biopharma Intelligence
May 17, 2024 5:38 PM UTC
After long being considered irrelevant for cancers, infectious diseases and large inflammatory conditions, gene therapy is increasingly seen as a promising treatment modality for these indications — in the form of vectorized antibodies. This year’s ASGCT meeting brought several new vectorized antibody designs.
Use of gene therapy has traditionally been restricted to rare genetic diseases, where viral vectors deliver a functional copy of the gene that’s lost or mutated in the disease to restore expression, thereby treating the underlying disease pathology…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652394/vectorized-antibodies-are-taking-gene-therapy-beyond-rare-disease